Beckman Coulter Buys Flow Cytometry Company
This is Beckman Coulter’s first acquisition since Danaher bought the company (see IBO 2/15/11). Blue Ocean Biomedical offers clinical systems, which employ automation for on-board sample preparation. The company has 28 full-time employees and many of its products are CE marked, according to Beckman Coulter.
Brea, CA 3/29/12—Beckman Coulter Life Sciences has acquired Blue Ocean Biomedical for an undisclosed amount. Blue Ocean Biomedical manufactures reagents and automated flow cytometry systems with integrated automated sample preparation for routine clinical analyses. “The simplification of customer workflows will be dramatic,” said Scott Atkin, president of Beckman Coulter Life Sciences. “We’ll be able to offer customers an extended line of market leading technology while expanding our reach within a key segment for flow cytometry.” The systems are currently only available in the EU.
